Discipline Wealth Solutions LLC Invests $314,000 in Danaher Co. (NYSE:DHR)

Discipline Wealth Solutions LLC bought a new position in Danaher Co. (NYSE:DHR) in the third quarter, HoldingsChannel reports. The fund bought 1,131 shares of the conglomerate’s stock, valued at approximately $314,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DHR. Soltis Investment Advisors LLC lifted its position in shares of Danaher by 19.3% in the third quarter. Soltis Investment Advisors LLC now owns 1,563 shares of the conglomerate’s stock worth $434,000 after buying an additional 253 shares in the last quarter. TD Private Client Wealth LLC raised its holdings in shares of Danaher by 1.0% during the 3rd quarter. TD Private Client Wealth LLC now owns 17,946 shares of the conglomerate’s stock worth $4,989,000 after acquiring an additional 169 shares in the last quarter. Coldstream Capital Management Inc. boosted its position in shares of Danaher by 6.7% during the 3rd quarter. Coldstream Capital Management Inc. now owns 16,318 shares of the conglomerate’s stock valued at $4,512,000 after acquiring an additional 1,019 shares during the last quarter. Prestige Wealth Management Group LLC grew its holdings in shares of Danaher by 22.0% in the third quarter. Prestige Wealth Management Group LLC now owns 1,528 shares of the conglomerate’s stock valued at $425,000 after purchasing an additional 276 shares in the last quarter. Finally, Adalta Capital Management LLC increased its position in Danaher by 52.3% in the third quarter. Adalta Capital Management LLC now owns 8,467 shares of the conglomerate’s stock worth $2,356,000 after purchasing an additional 2,907 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 0.6 %

NYSE DHR opened at $234.45 on Wednesday. The company’s 50-day simple moving average is $249.91 and its two-hundred day simple moving average is $258.14. Danaher Co. has a one year low of $217.96 and a one year high of $281.70. The company has a market capitalization of $169.34 billion, a price-to-earnings ratio of 44.74, a price-to-earnings-growth ratio of 4.23 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. Danaher’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.02 earnings per share. Equities analysts forecast that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.46%. Danaher’s payout ratio is currently 20.61%.

Analyst Upgrades and Downgrades

A number of brokerages have commented on DHR. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Thursday, December 5th. Robert W. Baird lowered their price objective on Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price for the company in a report on Thursday, October 31st. Barclays lowered their price target on Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. Finally, Stifel Nicolaus lifted their price objective on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research note on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $287.16.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.